InsidersTradesSigma
Track the 한국파마 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 한국파마 has published 56 insider filings. Market capitalisation: €81.8bn. The latest transaction was filed on 28 May 2026 (Other). Among the most active insiders: 박은희. All data is free.
54
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,393 of 29,064 companies
24.6
score / 100
Value24
Quality25
FCF yld1.6%
Earn yld-3.0%
EV/EBITDA57.0x
ROE-1.1%
Gross mgn36%
Net mgn-3.0%
Debt/EBITDA17.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 May 2026
Declarations56 total
Other
Other
25 of 56 declarations
关于 한국파마
한국파마 是一家专注于健康和制药领域的公司。该公司在 XKRX 市场上市。